Breast Cancer

References

Citations

1. American Cancer Society (2009). What are the risk factors for breast cancer? Detailed guide: Breast cancer. Cancer Reference Information. Available online: http://www.cancer.org/docroot/CRI/content/CRI_2_4_2X_What_are_the_risk_factors_for_breast_cancer_5.asp.

2. National Comprehensive Cancer Network (2009). Breast cancer screening and diagnosis. NCCN Clinical Practice Guidelines in Oncology, Version 1. Available online: http://www.nccn.org/professionals/physician_gls/PDF/breast-screening.pdf.

3. Beral V; Million Women Study Collaborators (2003). Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet, 362(9382): 419–427.

4. Women's Health Initiative Steering Committee (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA, 291(14): 1701–1712.

5. National Cancer Institute (2006). Probability of breast cancer in American women. National Cancer Institute Fact Sheet. Available online: http://www.cancer.gov/cancertopics/factsheet/Detection/probability-breast-cancer.

6. Willett WC, et al. (2004). Nongenetic factors in the causation of breast cancer. In JR Harris et al., eds., Diseases of the Breast, 3rd ed., pp. 223–276. Philadelphia: Lippincott Williams and Wilkins.

7. Beral V, et al. (2007). Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet, 369(9574): 1703–1710.

8. American Cancer Society (2007). Breast Cancer Facts and Figures 2007. Atlanta: American Cancer Society. Available online: http://www.cancer.org/docroot/STT/stt_0.asp.

9. Paley PJ (2001). Screening for the major malignancies affecting women: Current guidelines. American Journal of Obstetrics and Gynecology, 184(5): 1021–1030.

10. Gradishar WJ (2004). Male breast cancer. In JR Harris et al., eds., Diseases of the Breast, 3rd ed., pp. 983–990. Philadelphia: Lippincott Williams and Wilkins.

11. Veronesi U, et al. (2003). A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. New England Journal of Medicine, 349(6): 546–553.

12. Mansel RE, et al. (2006). Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC trial. Journal of the National Cancer Institute, 98(9): 599–609.

13. Wolff AC, et al. (2007). American Society of Clinical Oncology/College of American Pathologists Guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Journal of Clinical Oncology, 25(1): 118–145.

14. Martelli G, et al. (2005). A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: Results after 5 years of follow-up. Annals of Surgery, 242(1): 1–6.

15. Thurlimann B, et al. (2005). A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. New England Journal of Medicine, 353(26): 2747–2757.

16. Boccardo F, et al. (2007). Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma. Cancer, 109(6): 1060–1067.

17. Chlebowski T, et al. (2003). Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative randomized trial. JAMA, 289(24): 3243–3253.

18. Beral V, et al. (2002). Breast cancer and breastfeeding: Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50,302 women with breast cancer and 96,973 women without disease. Lancet, 360(9328): 187–2218.

19. Dallal CM, et al. (2007). Long-term recreational physical activity and risk of invasive and in situ breast cancer. Archives of Internal Medicine, 167(4): 408–415.

20. U.S. Department of Health and Human Services (2008). 2008 Physical Activity Guidelines for Americans (ODPHP Publication No. U0036). Washington, DC: U.S. Government Printing Office. Available online: http://www.health.gov/paguidelines/pdf/paguide.pdf.

21. McTiernan A, et al. (2004). Recreational physical activity and the risk of breast cancer in postmenopausal women. JAMA, 290(10): 1331–1336.

22. Burstein HJ (2003). Breast cancer: Supportive measures and follow-up care. In B Furie et al., eds., Clinical Hematology and Oncology, pp. 763–768. Philadelphia: Churchill Livingstone.

23. Holmes MD, et al. (2005). Physical activity and survival after breast cancer diagnosis. JAMA, 293(20): 2479–2486.

24. Drouin JS, et al. (2006). Random control clinical trial on the effects of aerobic exercise training on erythocyte levels during radiation treatment for breast cancer. Cancer, 107(10): 2490–2495.

25. Ohira T, et al. (2006). Effect of weight training on quality of life in recent breast cancer survivors: The Weight Training for Breast Cancer Survivors (STBS) study. Cancer, 106(9): 2076–2083.

26. Collado-Hidalgo A, et al. (2006). Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clinical Cancer Research, 12(9): 2759–2766.

27. National Comprehensive Cancer Network (2009). Breast cancer risk reduction. NCCN Clinical Practice Guidelines in Oncology, Version 1. Available online: http://www.nccn.org/professionals/physician_gls/PDF/breast_risk.pdf.

28. National Cancer Institute (2008). Breast Cancer PDQ: Treatment–Health Professional Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/breast/healthprofessional.

Go to previous section	Go to top of page	Go to next section
Author:	Bets Davis, MFA	Last Updated: August 18, 2009
Medical Review:	Joy Melnikow, MD, MPH - Family Medicine Douglas A. Stewart, MD - Medical Oncology
© 1995-2009 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.